BOB Intellectual Property Service Ltd.
  • 中文
  • 日本語
  • English
  • Company profile
    • About Us
    • Affiliated Law Firm
    • BOB Clients
    • BOB News
    • Join us
      • Client Service Department
      • Law Affair Department
      • Trademark Department
      • Investigation Department
      • Other Departments
    • Contact Us
  • Service associated
    with Trademark
    • Trademark Application
      • Trademark Search
      • Procedures of trademark registration
    • Trademark monitoring
    • Opposition of trademark
    • Registration similar trademarks
    • Protection of trademark right
    • Fees Information
  • Other Intellectual
    Property Service
    • Copyright registration
    • Patent and design service
  • IPR Protection
    Department
    • Anti-counterfeiting Services
    • Patent protection service
    • Customs protection service
    • Exhibition investigation and rights protection services
    • Anti-trade name unfair competition service
    • Litigation and other legal services
    • Quotation List
  • Solutions To
    Online Infringement
    • Online protection service
    • Features
    • Procedure and cases
  • Reference information
    • News & Insights
      • China IPR News
      • BOB Articles
      • Newsletter
    • Laws & Regulations
      • Trademark
      • Patent
      • Copyright
      • Unfair Competition、Trade Secret
      • Trade Name
      • New Plant Varieties
      • Customs
      • Exhibition
      • Food and Medicine
      • Internet and Domain Name
      • Criminal Cases
      • Notarization
      • International Treaty
      • Others
    • Anti-counterfeiting Campaigns
      • Trademark
      • Patent
      • Copyright
      • Unfair Competition
      • New Plant Varieties
      • Customs
      • Exhibition
      • Food and Medicine
      • Internet and Domain Name
      • Criminal Cases
      • Others
  • Free Consultation
China IPR News
Home » News & Insights » China IPR News » 【Patent】Anti-cancer drug with annual sales of 3.9 billion yuan is accused of patent infringement, BGNE will defend vigorously

【Patent】Anti-cancer drug with annual sales of 3.9 billion yuan is accused of patent infringement, BGNE will defend vigorously

BOBアーカイブ
  • China IPR News
  • BOB Articles
  • Newsletter


Company profile

  • About Us
  • Affiliated Law Firm
  • BOB Clients
  • BOB News
  • Join Us
  • Contact Us

Services

  • Service associated with Trademark
  • Other Intellectual Property Service
  • IPR Protection Department
  • Solutions To Online Infringement
  • Perennial Advisory Service

News & Insights

  • China IPR News
  • BOB Articles
  • Newsletter

Laws & regulations

  • Trademark
  • Patent
  • Copyright
  • Unfair Competition、Trade Secret
  • Trade Name
  • New Plant Varieties
  • Customs
  • Exhibition
  • Food and Medicine
  • Internet and Domain Name
  • Criminal Cases
  • Notarization
  • International Treaty
  • Others

Anti-counterfeiting Campaigns

  • Trademark
  • Patent
  • Copyright
  • Unfair Competition
  • New Plant Varieties
  • Customs
  • Exhibition
  • Food and Medicine
  • Internet and Domain Name
  • Criminal Cases
  • Others

Contact

  • Free Consultation
©2016 BOB Intellectual Property Service Ltd. All rights reserved. 沪ICP备07020976号-1